P&G Hygiene Profit Down 46% in June Quarter | Rs 81 cr
By Rediff Money Desk, New Delhi Aug 28, 2024 19:36
Procter & Gamble Hygiene and Health Care Ltd (PGHH) reported a 46.40% decline in profit after tax at Rs 81.06 crore for June quarter 2024 due to increased spending. Revenue from operations was at Rs 931.75 crore.
New Delhi, Aug 28 (PTI) Procter & Gamble Hygiene and Health Care Ltd (PGHH) on Wednesday reported 46.40 per cent decline in profit after tax at Rs 81.06 crore for June quarter 2024 on account of increased spending.
The company, which follows July-June financial year, had reported a profit after tax of Rs 151.24 crore in the corresponding quarter of the previous fiscal.
However, PGHH's revenue from operations was at 931.75 crore as against Rs 852.53 crore a year ago.
"PAT for the quarter was Rs 81 crore, with an increase in spending for demand generation to support innovation in healthcare and feminine care," said an earning statement from PGHH.
Total expense was at Rs 826.78 crore, up 26 per cent year-on-year.
Total income of the Proctor & Gamble entity, which has a portfolio of Vicks in healthcare and Whisper in feminine care, was up 8.86 per cent to Rs 939.06 crore.
For the full year, PGHH's profit after tax was flat at Rs 675.02 crore as against Rs 678.14 crore in the previous year.
"Reported PAT was flat vs year ago driven by the significant impact of one-time tax-related items both in the base period and current period," it said.
Revenue for the year was at Rs 4,205.70 crore, up 7.34 per cent.
This sales growth was "owing to innovation, premiumization and driving category growth in the feminine hygiene category".
Shares of PGHH on Wednesday settled at Rs 16,980.80 apiece on BSE, down 0.22 per cent from the previous close.
The company, which follows July-June financial year, had reported a profit after tax of Rs 151.24 crore in the corresponding quarter of the previous fiscal.
However, PGHH's revenue from operations was at 931.75 crore as against Rs 852.53 crore a year ago.
"PAT for the quarter was Rs 81 crore, with an increase in spending for demand generation to support innovation in healthcare and feminine care," said an earning statement from PGHH.
Total expense was at Rs 826.78 crore, up 26 per cent year-on-year.
Total income of the Proctor & Gamble entity, which has a portfolio of Vicks in healthcare and Whisper in feminine care, was up 8.86 per cent to Rs 939.06 crore.
For the full year, PGHH's profit after tax was flat at Rs 675.02 crore as against Rs 678.14 crore in the previous year.
"Reported PAT was flat vs year ago driven by the significant impact of one-time tax-related items both in the base period and current period," it said.
Revenue for the year was at Rs 4,205.70 crore, up 7.34 per cent.
This sales growth was "owing to innovation, premiumization and driving category growth in the feminine hygiene category".
Shares of PGHH on Wednesday settled at Rs 16,980.80 apiece on BSE, down 0.22 per cent from the previous close.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Srestha Finvest
- 0.89 ( 0.00)
- 69758135
- Standard Capital
- 1.26 ( -16.00)
- 55792425
- GTL Infrastructure
- 2.37 (+ 4.87)
- 50169700
- Vodafone Idea L
- 9.18 ( -1.50)
- 27130818
- Jaiprakash Power Ven
- 22.33 ( -2.45)
- 21183721
MORE NEWS
Gold Price Jumps Rs 1,150 to Rs 78,500/10g:...
Gold prices surged Rs 1,150 to Rs 78,500/10g in India, driven by positive global trends...
Sebi Halts Trafiksol IPO Listing, Orders Probe
Sebi has ordered an investigation into Trafiksol ITS Technologies' IPO disclosures...
Wockhardt's Antibiotic for CABP Gets CDSCO...
Wockhardt receives a favourable recommendation from CDSCO for its novel antibiotic,...